59 studies found for:    Open Studies | "Pigmentation Disorders"
Show Display Options
Rank Status Study
21 Unknown  Evaluation of Response of Dasatinib to Treat Mastocytosis
Condition: Systemic Mastocytosis
Intervention: Drug: Dasatinib
22 Recruiting Photocil (Topical) for the Treatment of Vitiligo
Condition: Vitiligo
Interventions: Drug: Photocil for Vitiligo;   Other: Placebo - Sunscreen (SPF 2)
23 Recruiting Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo
Condition: Vitiligo
Interventions: Biological: Outer-Root-Sheath Melanocytes Suspension;   Biological: Placebo
24 Recruiting A Multicenter Trial of Non-cultured Epidermal Cellular Grafting Versus Hyaluronic Acid for Repigmenting Stable Leukoderma (Vitiligo and Piebaldism)
Conditions: Vitiligo;   Piebaldism
Interventions: Device: VITICELL;   Device: PLACEBO
25 Unknown  Punchgrafting Techniques for Vitiligo
Conditions: Non-segmental Vitiligo;   Segmental Vitiligo;   Piebaldism
Intervention: Procedure: punchgrafting
26 Recruiting Midostaurin in Indolent Systemic Mastocytosis
Condition: Indolent Systemic Mastocytosis
Intervention: Drug: Midostaurin,
27 Unknown  Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo
Condition: Vitiligo
Intervention: Dietary Supplement: GINGKO BILOBA
28 Unknown  Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
Conditions: Patients With Active Non-segmental Vitiligo.;   Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05%;   Cream Compared to NB-UVB Alone in Patients With Non-segmental Vitiligo
Intervention: Drug: Fluticasone proprionate 0.05% cream
29 Unknown  Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?
Condition: Kidney Failure, Chronic
Intervention: Drug: vitamin C, intravenous injection
30 Recruiting Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways
Conditions: Atopic Dermatitis;   Netheron's Syndrome;   Piebaldism;   Hyper IgE Syndrome;   Ichthyosis;   Anaphylaxis;   Severe Allergy
Intervention:
31 Recruiting The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients
Condition: Mastocytosis
Intervention: Drug: injections
32 Recruiting Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
Condition: Vitiligo
Interventions: Drug: topical tacrolimus treatment;   Drug: topical pimecrolimus treatment;   Drug: local mometasone furoate treatment;   Drug: cold cream
33 Recruiting NB-UVB and PUVA Vitiligo Study
Condition: Vitiligo
Interventions: Other: Phototherapy;   Other: Phototherapy and Photochemotherapy
34 Not yet recruiting The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism
Conditions: Ocular Albinism (OA);   Oculocutaneous Albinism (OCA)
Interventions: Dietary Supplement: Lutein plus Zeaxanthin;   Dietary Supplement: Placebo
35 Recruiting Efficacy and Safety of Biocellulose Sheet Containing Anti-hyperpigmentation Agent ("Biocellulose Mask", "Farhorm®") in Patients Receiving Laser Treatment
Conditions: Skin Pigmentation;   Skin Irritation
Intervention: Device: "Biocellulose Mask", Farhorm®"
36 Recruiting Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
Conditions: Aggressive Systemic Mastocytosis;   Mast Cell Leukemia;   Systemic Mastocytosis
Interventions: Drug: brentuximab vedotin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment;   Other: questionnaire administration
37 Recruiting Vision Response to Dopamine Replacement
Conditions: Albinism;   Oculocutaneous Albinism
Intervention: Drug: Levodopa/carbidopa
38 Not yet recruiting Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study
Condition: Idiopathic Guttate Hypomelanosis
Intervention: Device: Excimer Light Treatment
39 Recruiting A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Conditions: Adult Acute Lymphoblastic Leukemia in Remission;   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Aplastic Anemia;   Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Myelodysplastic Syndromes;   Chronic Eosinophilic Leukemia;   Chronic Myelomonocytic Leukemia;   Chronic Neutrophilic Leukemia;   Essential Thrombocythemia;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Juvenile Myelomonocytic Leukemia;   Mastocytosis;   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Nodal Marginal Zone B-cell Lymphoma;   Polycythemia Vera;   Previously Treated Myelodysplastic Syndromes;   Primary Myelofibrosis;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Refractory Anemia;   Refractory Anemia With Ringed Sideroblasts;   Refractory Hairy Cell Leukemia;   Refractory Multiple Myeloma;   Secondary Myelodysplastic Syndromes;   Splenic Marginal Zone Lymphoma;   T-cell Large Granular Lymphocyte Leukemia;   Waldenström Macroglobulinemia
Interventions: Drug: Fludarabine;   Drug: Thiotepa;   Radiation: Total Body Irradiation (TBI);   Biological: Donor Lymphocyte Infusion (DLI);   Drug: Cyclophosphamide (CY);   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Device: Allogeneic hematopoietic stem cell transplantation;   Procedure: Peripheral blood stem cell transplantation (PBSCT)
40 Recruiting Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Conditions: Cockayne Syndrome;   Skin Cancer;   Xeroderma Pigmentosum;   Trichothiodystrophy;   Genodermatosis
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-59) Show next page of results
Indicates status has not been verified in more than two years